Drugs / Allogeneic Bone Marrow
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00062712 | Jun 2003 → Mar 2007 | — | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic Bone Marrow | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00062712 ↗ |
| Modality | Cell therapy | “cells from the donor's bone marrow” NCT00062712 ↗ |
| Route | Other | “donor bone marrow infusion” NCT00062712 ↗ |